Pangaea Oncology, S.A. (BME:PANG)
Spain · Delayed Price · Currency is EUR 1.430
0.00 (0.00%)
Sep 15, 2026, 4:00 PM CET
Pangaea Oncology Market Cap
Pangaea Oncology has a market cap or net worth of €51.36 million as of September 16, 2026. Its market cap has decreased by -13.09% in one year.
Market Cap
51.36M
Enterprise Value
53.78M
Revenue
16.73M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.43
ChartMarket Cap Chart
Since December 29, 2016, Pangaea Oncology's market cap has increased from 30.03M to 51.36M, an increase of 71.03%. That is a compound annual growth rate of 5.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 51.36M | -13.03% |
| Dec 31, 2025 | 59.05M | -2.89% |
| Dec 31, 2024 | 60.81M | 12.24% |
| Dec 29, 2023 | 54.18M | 8.35% |
| Dec 30, 2022 | 50.00M | 41.34% |
| Dec 30, 2021 | 35.38M | 30.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.86B |
| Laboratorios Farmaceuticos Rovi | 2.93B |
| Almirall | 2.22B |
| Faes Farma | 1.39B |
| Oryzon Genomics | 228.51M |
| Prim, S.A. | 217.71M |
| Laboratorio Reig Jofre | 215.74M |
| Atrys Health | 204.95M |